Dermatology
News
Antibiotic choices for inpatients with SSTIs vary by race
Clindamycin was more often prescribed for Black patients than White patients.
Article
Dark plaque on back of ear
News from the FDA/CDC
FDA approves two JAK-1 inhibitors for moderate to severe atopic dermatitis
“It’s big news because a few years ago we didn’t have any systemic treatments that are safer than the classical immunosuppressants.”
News
FDA updates status of iPLEDGE access problems
The Isotretinoin Products Manufacturers Group has “created a new tool within the system to help resolve account access for some user groups...
DermaDiagnosis
Sometimes You Can’t Blame the Sun
A 60-year-old woman complains of “sunburn” and increased weakness. What should your work-up include?
Article
Plaque on heel
Conference Coverage
Key questions to ask atopic dermatitis patients with sleep complaints
Assessment tools to consider are the Epworth Sleepiness Scale, the Insomnia Severity Index, and the STOP-Bang questionnaire.
Conference Coverage
Longitudinal course of atopic dermatitis often overlooked, expert says
“Understanding the long-term course may improve our ability to phenotype, prognosticate, and personalize our care,” Dr. Raj Chovatiya said.
News
FDA to review PDE4-inhibitor roflumilast for psoriasis
The target action date for approval for the topical psoriasis treatment is in July 2022.
News from the FDA/CDC
FDA gives nod to tralokinumab for adults with moderate to severe AD
The drug is expected to be available by February 2022.